Welminic-P Syrup is a combination pharmaceutical formulation containing Chlorpheniramine Maleate (1mg/5ml), Paracetamol (125mg/5ml), and Phenylephrine (5mg/5ml), designed for the symptomatic relief of common cold and allergic conditions. Chlorpheniramine Maleate, an antihistamine, alleviates allergic symptoms such as sneezing, runny nose, and watery eyes by blocking H1 histamine receptors. Paracetamol serves as an analgesic and antipyretic agent, effectively reducing fever and relieving mild to moderate pain. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, acts as a nasal decongestant by causing vasoconstriction in the nasal mucosa, thereby reducing swelling and congestion. This combination is particularly useful in managing symptoms associated with upper respiratory tract infections, allergic rhinitis, and sinusitis. Welminic-P Syrup should be administered according to the prescribed dosage to minimize the risk of adverse effects such as drowsiness, gastrointestinal discomfort, or increased blood pressure. It is contraindicated in patients with hypersensitivity to any of the components, severe hypertension, or cardiovascular disorders. Caution is advised in patients with liver impairment or those taking monoamine oxidase inhibitors. Consultation with a healthcare professional is recommended before use, especially in pediatric, geriatric, or pregnant populations.